Yousif Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $511K | Sell |
1,567
-106
| -6% | -$34.6K | 0.01% | 1447 |
|
|
2025
Q1 | $452K | Buy |
1,673
+31
| +2% | +$8.37K | 0.01% | 1479 |
|
|
2024
Q4 | $386K | Buy |
1,642
+9
| +0.6% | +$2.12K | ﹤0.01% | 1582 |
|
|
2024
Q3 | $449K | Buy |
1,633
+20
| +1% | +$5.5K | ﹤0.01% | 1542 |
|
|
2024
Q2 | $392K | Sell |
1,613
-22
| -1% | -$5.35K | ﹤0.01% | 1579 |
|
|
2024
Q1 | $244K | Buy |
1,635
+144
| +10% | +$21.5K | ﹤0.01% | 1811 |
|
|
2023
Q4 | $285K | Buy |
1,491
+45
| +3% | +$8.61K | ﹤0.01% | 1769 |
|
|
2023
Q3 | $256K | Buy |
1,446
+40
| +3% | +$7.08K | ﹤0.01% | 1764 |
|
|
2023
Q2 | $267K | Sell |
1,406
-21
| -1% | -$3.99K | ﹤0.01% | 1758 |
|
|
2023
Q1 | $286K | Buy |
1,427
+50
| +4% | +$10K | ﹤0.01% | 1717 |
|
|
2022
Q4 | $327K | Buy |
1,377
+245
| +22% | +$58.2K | ﹤0.01% | 1677 |
|
|
2022
Q3 | $227K | Buy |
+1,132
| New | +$227K | ﹤0.01% | 1776 |
|
|
2022
Q2 | – | Sell |
-1,751
| Closed | -$286K | – | 1978 |
|
|
2022
Q1 | $286K | Buy |
1,751
+70
| +4% | +$11.4K | ﹤0.01% | 1816 |
|
|
2021
Q4 | $285K | Buy |
+1,681
| New | +$285K | ﹤0.01% | 1840 |
|